kallidin, des-arg(10)- has been researched along with enalapril in 1 studies
Studies (kallidin, des-arg(10)-) | Trials (kallidin, des-arg(10)-) | Recent Studies (post-2010) (kallidin, des-arg(10)-) | Studies (enalapril) | Trials (enalapril) | Recent Studies (post-2010) (enalapril) |
---|---|---|---|---|---|
80 | 4 | 17 | 6,311 | 1,924 | 859 |
Protein | Taxonomy | kallidin, des-arg(10)- (IC50) | enalapril (IC50) |
---|---|---|---|
Angiotensin-converting enzyme | Homo sapiens (human) | 0.3536 | |
Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 2.7083 | |
Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 1.2 | |
Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 0.14 | |
Angiotensin-converting enzyme 2 | Homo sapiens (human) | 0.14 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cruden, NL; Fox, KA; Ludlam, CA; Megson, I; Newby, DE; Tse, GH | 1 |
1 trial(s) available for kallidin, des-arg(10)- and enalapril
Article | Year |
---|---|
B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure.
Topics: Adolescent; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bradykinin B1 Receptor Antagonists; Cross-Over Studies; Enalapril; Female; Fibrinolysis; Forearm; Heart Failure; Humans; In Vitro Techniques; Kallidin; Losartan; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Pregnancy; Receptor, Bradykinin B1; Regional Blood Flow; Tissue Plasminogen Activator; Umbilical Veins; Vasoconstriction | 2005 |